SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT AGREEMENT (“Amendment”) is made and entered into as of May 26, 2009, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and Worldwide Officers, Inc. a California Corporation (the “Lender”). Capitalized terms used herein and undefined shall have the meanings set forth in that certain Loanout Agreement (defined in the] [SKYSTAR BIO-PHARMACEUTICAL COMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province People’s Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen: Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), is pleased to offer you a director position on]

By | 2016-03-01T08:05:46+00:00 May 27th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT

[AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT AGREEMENT (“Amendment”) is made and entered into as of May 26, 2009, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and Worldwide Officers, Inc. a California Corporation (the “Lender”). Capitalized terms used herein and undefined shall have the meanings set forth in that certain Loanout Agreement (defined in the] [SKYSTAR BIO-PHARMACEUTICAL COMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province People’s Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen: Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), is pleased to offer you a director position on]

By | 2016-03-01T08:07:36+00:00 May 27th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

LONG [eLong,] 6-K: (Original Filing)

[eLong, Inc. Reports First Quarter 2009 Unaudited Financial Results BEIJING, China — May 27, 2009 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March 31, 2009. Highlights • Total gross revenues net revenues • Travel revenues before business tax and surcharges (figures in RMB 000’s;]

By | 2016-03-02T13:04:40+00:00 May 27th, 2009|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

LONG [eLong,] 6-K: eLong, Inc. Reports First Quarter 2009 Unaudited Financial

[eLong, Inc. Reports First Quarter 2009 Unaudited Financial Results BEIJING, China — May 27, 2009 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March 31, 2009. Highlights • Total gross revenues net revenues • Travel revenues before business tax and surcharges (figures in RMB 000’s;]

By | 2016-03-02T13:06:57+00:00 May 27th, 2009|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments

CSUN [China Sunergy] 6-K: (Original Filing)

[CHINA SUNERGY ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2009 Nanjing, China – May 27, 2009 – China Sunergy Co., Ltd. (Nasdaq: CSUN), (“China Sunergy” or the “Company”) a specialized solar cell manufacturer based in Nanjing, China, announced today its financial results for the first quarter of 2009. First Quarter Financial Results · Revenues were US$37.0 million, a 14.4%]

By | 2016-03-07T15:24:18+00:00 May 27th, 2009|Categories: Chinese Stocks, CSUN, SEC Original|Tags: , , , , , |0 Comments

SEED [Origin Agritech] 6-K: (Original Filing)

[Origin Agritech Limited Reports Second Quarter Financial Results Advances from Customers for Q2 09 were RMB 165.21 million from RMB 105.17 million in Q2 08, an increase of 57.09% Deferred Revenues for Q2 09 were RMB 443.40 million from RMB 400.15 million in Q2 08, an increase of 10.80% Origin Agritech Limited (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--May 26, 2009--]

By | 2016-03-10T22:13:39+00:00 May 27th, 2009|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments

SEED [Origin Agritech] 6-K: Origin Agritech Limited Reports Second Quarter Financial Results

[Origin Agritech Limited Reports Second Quarter Financial Results Advances from Customers for Q2 09 were RMB 165.21 million from RMB 105.17 million in Q2 08, an increase of 57.09% Deferred Revenues for Q2 09 were RMB 443.40 million from RMB 400.15 million in Q2 08, an increase of 10.80% Origin Agritech Limited (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--May 26, 2009--]

By | 2016-03-10T22:14:40+00:00 May 27th, 2009|Categories: Chinese Stocks, SEED, Webplus ver|Tags: , , , , , |0 Comments

JRJC [China Finance Online] 6-K: (Original Filing)

[CHINA FINANCE ONLINE REPORTS UNAUDITED FIRST QUARTER 2009 RESULTS (Beijing, China, May 26, 2009) China Finance Online Co. Limited (NASDAQ: JRJC), a leading Chinese online financial information and listed company data provider, today announced its financial results for the first quarter ended March 31, 2009: Q1 2009 Highlights First Quarter 2009 2008 (in thousands of U.S. dollars, except per ADS] [Form 6-K May 26, 2009 China Finance Online Co. Limited Hong Kong (Jurisdiction of incorporation or organization) 9th Floor of Tower C, Corporate Square þ o o o o þ n/a China Finance Online Co. Limited Jun Wang Chief Financial Officer 2 Description 99.1 CHINA FINANCE ONLINE REPORTS UNAUDITED FIRST QUARTER 2009 RESULTS 3 6-K 1 c86084e6vk.htm FORM 6-K]

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[AMENDMENT TO LOANOUTREEMENT THIS AMENDMENT TO LOANOUTREEMENT (Amendment) is made and entered into of May 26, 2009, by and betweenystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), and Worldwide Officers, aliforniarporation (the Lender).pitalized terms used herein and undefined shall have the meanings set forth in that certain Loanoutreement (defined in the Recitals below).] [SKYSTAR BIO-PHARMACEUTICALMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province Peoples Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen:ystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), is pleased to offer you a director position on]

By | 2016-02-05T05:48:00+00:00 May 27th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar